1. Aarti Drugs
stock logo

50% Buy

Aarti Drugs Share Price

AARTIDRUGS

₹499.85+₹6.50 (1.32%) Past YearLast updated on 23 Apr, 2024 | 03:52 PM IST
₹492.25₹504.95
L
Show Current Price
H
  • News

  • Company overview

  • Fundamentals

  • Events

  • More

Company overview

About

arrow

Market cap

Market Cap Switch₹4,595 Cr

Open

₹495.90

Close

₹493.35

Circuit range

₹592.00 - ₹394.70

Day range

₹492.25 - ₹504.95

Year range

₹409.00 - ₹645.75

Volume

3,60,824

Avg. traded

₹497.52

Revenue (12m)

₹2,651 Cr

Aarti DrugsAarti Drugs Limited is an India-based company that is engaged in the manufacturing of active pharmaceutical ingredients (APIs), pharma intermediates, specialty chemicals and formulations. The Company operates through pharmaceuticals segment. The Company's APIs products include ciprofloxacin hydrochloride, metronidazole, metformin HCL, ketoconazole and ofloxacin, among others. Its specialty chemicals products include benzene sulphonyl chloride and methyl nicotinate, among others. Its pharma intermediates products include tinidazole, celecoxib, ciprofloxacin, clopidogrel, diclofenac, ketoconazole, raloxifene and zolpidem. Its products under development include itraconazole, fluconazole, dabigatran, ticagrelor, sitagliptin and alpha lipoic acid. The Company's subsidiaries include Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited and Pinnacle Chile SPA.

Read more

Aarti Drugs Key indicators

arrow

52 week high

₹645.75

52 week low

₹409.00

P/E ratio

25.61

P/B ratio

3.64

ROE

14.65%

ROCE

15.38%

Dividend yield

0.2%

Debt/Equity ratio

0.48

EPS

16.5

Learn more

Investment checklist: (4/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst ratings:

Buy

arrow

Buy

50%

Hold

50%

Sell

0%

This analysis is based on the reviews of 2 experts in the last 7 days

Fundamentals

Financial ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

11.54%

Net profit margin

6.12%

ROE

14.65%

ROA

7.23%

ROCE

15.38%

Learn more

Aarti Drugs Shareholder returns

arrow

1 day

-0.33%

1 week

-2.15%

1 month

+8.29%

3 months

-8.11%

1 year

+16.56%

3 years

-32.19%

5 years

+217.86%

Revenue statement

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

Cash flow

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

Balance sheet

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

Aarti Drugs Share Price history

arrow
DayOpenCloseDay’s change
Mon, Apr 22 2024
₹495.00
₹493.35
-0.33%
Fri, Apr 19 2024
₹490.00
₹495.00
+1.01%
Thu, Apr 18 2024
₹496.00
₹492.35
-0.74%
Tue, Apr 16 2024
₹490.60
₹494.75
+0.84%
Mon, Apr 15 2024
₹491.10
₹490.60
-0.10%
Fri, Apr 12 2024
₹506.10
₹504.20
-0.38%
Wed, Apr 10 2024
₹513.05
₹507.95
-1.00%
Tue, Apr 9 2024
₹495.00
₹513.05
+3.52%

Shareholding info

arrow

Promoters (57.13%)

Mutual Funds (5.08%)

Retail and other (34.31%)

Foreign institutions-FII (2.56%)

Other domestic institutions (0.91%)

Promoters

Learn more

Events

Corporate actions

arrow
  • Dividend • ₹1/share

    Ex date 06 Feb 2024

    expand tab
  • Dividend • ₹1/share

    Ex date 08 Feb 2023

    expand tab
  • Dividend • ₹1/share

    Ex date 09 Feb 2022

    expand tab

Learn more

Frequently asked questions